GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM49933
Query DataSets for GSM49933
Status
Public on May 03, 2005
Title
Contusion - 35 Day Epicenter Rep1
Sample type
RNA
Source name
Spinal Cord, Epicenter (~T8)
Organism
Rattus norvegicus
Extracted molecule
total RNA
Description
RNA characterization of tissue from the injury site, 35 days post-injury. From the Christopher Reeve Paralysis Foundation Research Consortium microarray study (www.crpf.org/microarray)
Submission date
Apr 29, 2005
Last update date
May 27, 2005
Contact name
James Bradley Aimone
E-mail(s)
[email protected]
Phone
858-453-4100 x1876
Organization name
Salk Institute
Department
Laboratory of Genetics
Lab
Gage
Street address
10010 N. Torrey Pines Rd
City
La Jolla
State/province
CA
ZIP/Postal code
92037
Country
USA
Platform ID
GPL85
Series (1)
GSE2599
Chronic contusion spinal cord injury in rats
Data table header descriptions
ID_REF
VALUE
ABS_CALL
STD_DEV
Data table
ID_REF
VALUE
ABS_CALL
STD_DEV
AFFX-MurIL2_at
85.3409
A
3.59217
AFFX-MurIL10_at
94.7137
A
8.57013
AFFX-MurIL4_at
22.4472
A
2.28503
AFFX-MurFAS_at
1060.96
A
5.47555
AFFX-BioB-5_at
95.7814
P
4.62728
AFFX-BioB-M_at
93.3165
P
3.82676
AFFX-BioB-3_at
112.69
A
5.01611
AFFX-BioC-5_at
197.4
P
7.17346
AFFX-BioC-3_at
155.857
P
5.39482
AFFX-BioDn-5_at
238.28
P
10.131
AFFX-BioDn-3_at
1031.28
P
39.683
AFFX-CreX-5_at
1331.44
P
54.7758
AFFX-CreX-3_at
2111.95
P
77.9925
AFFX-BioB-5_st
151.914
A
1.7994
AFFX-BioB-M_st
104.78
A
2.27223
AFFX-BioB-3_st
46.6815
A
3.47904
AFFX-BioC-5_st
90.672
A
3.72521
AFFX-BioC-3_st
116.501
A
4.29142
AFFX-BioDn-5_st
316.604
A
17.8534
AFFX-BioDn-3_st
81.0505
A
5.02354
Total number of rows:
8799
Table truncated, full table size
267 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|